Full text is available at the source.
Abstract
Tirzepatide (TZP) treatment may improve clinical outcomes for patients experiencing weight regain and insufficient glycemic control after laparoscopic sleeve gastrectomy.
- Laparoscopic sleeve gastrectomy is associated with long-term weight regain and worsening of type 2 diabetes mellitus in some patients.
- TZP is a medication that acts on specific receptors related to insulin and glucose regulation.
- The study evaluates the effects of TZP on weight and blood sugar levels in patients with a history of weight regain post-surgery.
- Preliminary findings suggest that TZP may offer benefits for managing weight and glycemic control in these patients.
Simplified